atai Life Sciences acquires majority stake in Psyber, Inc., to develop Brain Computer Interface-enabled digital therapeutics targeting mental health disorders
Marijuana Stocks, Finance, & InvestingUncategorized April 8, 2021
atai acquires a majority stake in Delaware-based Psyber, Inc., which has a strong focus on digital therapeutics.
Read more
California Senators Approve Bill To Legalize Possession Of Psychedelics Like LSD, MDMA And Psilocybin
Marijuana Stocks, Finance, & InvestingUncategorized April 8, 2021
A bill to decriminalize psychedelics in California and create a working group to study broader reform advanced through a Senate committee on Tuesday.
Read more
Cannabis may have some beneficial effects on symptoms of obsessive-compulsive disorder
Marijuana Stocks, Finance, & InvestingUncategorized April 8, 2021
An analysis of a large dataset of medical cannabis users has indicates that many people with obsessive-compulsive disorder report that their symptoms are reduced after smoking the substance.
Read more
Why Dollar-Cost Averaging Makes Sense For Psychedelic Stocks
Marijuana Stocks, Finance, & InvestingUncategorized April 6, 2021
Psychedelic stocks have been battered by general market headwinds in recent weeks. Uncertainty could persist. How do investors allocate capital?
Read more
New research provides evidence that a single dose of psilocybin can boost brain connections
Marijuana Stocks, Finance, & InvestingUncategorized April 6, 2021
Scientists in Denmark believe the psychedelic substance psilocybin might produce rapid and lasting antidepressant effects in part because it enhances neuroplasticity in the brain.
Read more
Illinois Smashes Marijuana Sales Record, Exceeding $100 Million In March Illinois Smashes Marijuana Sales Record, Exceeding $100 Million In March
Marijuana Stocks, Finance, & Investing April 6, 2021 0
Illinois Smashes Marijuana Sales Record, Exceeding $100 Million In March
Monthly marijuana sales exceeded $100 million for the first time in Illinois in March, shattering the previous record.
Hard Numbers On The Huge Potential Of Psychedelic Drug Development
Marijuana Stocks, Finance, & InvestingUncategorized April 5, 2021
Drug development is expensive. It is also EXTREMELY lucrative. We take a close look at this revenue potential.
Read more
Microdosing psychedelic drugs associated with increases in conscientiousness and reductions in neuroticism
Marijuana Stocks, Finance, & InvestingUncategorized April 5, 2021
Microdosing has become something of a wellness trend in recent years, gathering traction in Australia and overseas.
Read moreMindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform
Marijuana Stocks, Finance, & InvestingUncategorized April 4, 2021
MindMed announces its year-end results for 2020, cash-on-hand at US$161 million, including a total cash burn for 2020 of US$24.2 million.
Read more
Cybin Announces Senior Management Changes to Lead Buildout of Development and Clinical Capabilities in the United States and Europe
Marijuana Stocks, Finance, & InvestingUncategorized April 4, 2021
Cybin announces senior management changes as it moves into the next stage of its evolution.
Read more
